Frequency, Timing, Burden and Recurrence of Adverse Events Following Immunization After HPV Vaccine Based on a Cohort Event Monitoring Study in the Netherlands

<b>Background/Objectives:</b> The aim of this study was to systematically assess Adverse Events Following Immunization (AEFI) among children following administration of the human papillomavirus (HPV) vaccine (Cervarix<sup>®</sup>) included in the Dutch National Immunization P...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Monika Raethke, Jeroen Gorter, Rachel Kalf, Leontine van Balveren, Rana Jajou, Florence van Hunsel
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Subjects:	HPV vaccination Adverse Events Following Immunization (AEFI) Dutch National Immunization Program cohort event monitoring (CEM)
Online Access:	https://www.mdpi.com/2076-393X/13/8/812

Similar Items

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
by: WANG Qian, et al.
Published: (2022-04-01)

Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system
by: Xuejiao Pan, et al.
Published: (2021-10-01)

Assessment of Causality, Severity and Seriousness of Adverse Event Following Immunization in Iraq: A Retrospective Study Based on Iraqi
by: Ahmad K. Abd, et al.
Published: (2019-12-01)

A national pharmacovigilance centre perspective on pandemic preparedness - lessons learned from the COVID-19 pandemic
by: Florence van Hunsel, et al.
Published: (2025-08-01)

Adverse Events Following Immunization with DTP Vaccine in Infants and Children in Kermanshah City: A Cohort Study
by: M Karami, et al.
Published: (2006-02-01)

Short-term adverse events after COVAXIN vaccination in adolescents (15–18 Years) in Northern India: Frequency, predictors, and reporting behavior
by: Sujoy Bose, et al.
Published: (2025-07-01)

Understanding and experience of adverse event following immunization (AEFI) and its consequences among healthcare providers in Kebbi State, Nigeria: a qualitative study
by: Semeeh Akinwale Omoleke, et al.
Published: (2022-06-01)

Investigation of Adverse Events Experienced by Healthcare Workers following Immunization with Homologous or Heterologous COVID-19 Booster Vaccinations
by: Yunhua Wei, et al.
Published: (2022-11-01)

Adverse event reporting following immunization of hepatitis B vaccine: A 13-year review
by: Xiaoying Gong, et al.
Published: (2024-12-01)

Building confidence in COVID-19 vaccine rollout: the importance of responsible presentation and follow-on investigation of Adverse Events Following Immunization (AEFI) reports for elderly patients
by: Razmin Bari, et al.
Published: (2024-02-01)

Intussusception and Other Adverse Event Surveillance after Pilot Introduction of Rotavirus Vaccine in Nam Dinh and Thua Thien Hue Provinces—Vietnam, 2017–2021
by: Ly Khanh Thi Le, et al.
Published: (2024-02-01)

Vaccine hesitancy: evidence from an adverse events following immunization database, and the role of cognitive biases
by: Hossein Azarpanah, et al.
Published: (2021-09-01)

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia
by: C.-M. Baxter, et al.
Published: (2018-08-01)

Farmacovigilancia de vacunas y su aplicación en Chile
by: Adiela Saldaña, et al.
Published: (2020-05-01)

Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine using the national adverse event following immunization surveillance system from Zhejiang province, 2018-2020
by: Yu Hu, et al.
Published: (2021-12-01)

Epidemiological study of adverse events following immunization in under 5 year children
by: Vikrant S Pagar, et al.
Published: (2021-01-01)

Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China
by: Yiqing Zhu, et al.
Published: (2025-12-01)

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature
by: Janneke W. Duijster, et al.
Published: (2023-01-01)

Factors influencing influenza vaccination coverage among kindergarten and primary school children in Zhejiang Province， 2023
by: LI Minchao, et al.
Published: (2025-01-01)

Risk of adverse events following CoronaVac's COVID-19 vaccination in women with and without autoimmunity
by: Stevent Sumantri, et al.
Published: (2023-03-01)

Trends of Adverse Events Following Immunization (AEFI) Reports of Human Papillomavirus Vaccine in the Valencian Community—Spain (2008–2018)
by: Cecilia M. Egoavil, et al.
Published: (2020-03-01)

Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China
by: Yu Hu, et al.
Published: (2022-01-01)

Utilizing group-based models to identify adverse event patterns after an intervention
by: Wei Wang, et al.
Published: (2025-09-01)

ADVERSE EVENTS FOLLOWING PENTAVALENT VACCINE ADMINISTRATION: A DESCRIPTIVE STUDY IN THE INDIAN CONTEXT
by: Roop Sharma, et al.
Published: (2025-05-01)

Safety assessment of seasonal trivalent influenza vaccine produced by Instituto Butantan from 2013 to 2017
by: Vera Lúcia Gattás, et al.
Published: (2018-12-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
by: Li Sun, et al.
Published: (2024-12-01)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
by: Xuejiao Pan, et al.
Published: (2022-01-01)

A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
by: Mohamed Serhan, et al.
Published: (2024-12-01)

Surveillance of psychogenic adverse events following immunization in Zhejiang, China, 2020–2023
by: Xuejiao Pan, et al.
Published: (2025-04-01)

A Cross-Sectional Study to Assess mRNA-COVID-19 Vaccine Safety among Indian Children (5–17 Years) Living in Saudi Arabia
by: Marya Ahsan, et al.
Published: (2023-01-01)

Surveillance of Adverse Events Following Varicella Vaccine Immunization in Zhejiang Province, China, from 2020 to 2022
by: Hui Liang, et al.
Published: (2025-01-01)

Subcutaneous nodules: an important adverse event following immunization
by: Rowena Silcock, et al.
Published: (2019-04-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
by: AbdulAzeez Adeyemi Anjorin, et al.
Published: (2022-04-01)

Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy
by: Antonio Di Lorenzo, et al.
Published: (2022-03-01)

Assessment of Mother’s Knowledge and Practices Regarding Adverse Events Following Immunization of Their Children in a Rural Area of Tripura
by: Anjan Datta, et al.
Published: (2017-04-01)

Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021
by: Dongmei Gao, et al.
Published: (2023-08-01)

Allergic adverse events following immunization: Data from post-marketing surveillance in Apulia region (South of Italy)
by: Pasquale Stefanizzi, et al.
Published: (2023-02-01)

Thoughts on fund compensation of adverse events following immunization in China
by: SU Ting, et al.
Published: (2022-04-01)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-07-01)

Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India
by: Aravind P. Gandhi, et al.
Published: (2023-03-01)